Quarter Period Consolidated Statement Of Income

Kubota Pharmaceutical Holdings Co., Ltd. - Filing #7271008

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Quarter period consolidated statement of income
Statement of income
Cost of sales
2,239,000 JPY
JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
66,839,000 JPY
65,922,000 JPY
Depreciation
128,000 JPY
4,350,000 JPY
Operating profit (loss)
-381,933,000 JPY
-145,889,000 JPY
Non-operating income
Interest income
8,116,000 JPY
6,187,000 JPY
Non-operating income
9,007,000 JPY
17,265,000 JPY
Non-operating expenses
Non-operating expenses
922,165,000 JPY
603,988,000 JPY
Ordinary profit (loss)
-1,295,091,000 JPY
-732,613,000 JPY
Extraordinary income
Extraordinary income
48,089,000 JPY
7,941,000 JPY
Extraordinary losses
Impairment losses
54,628,000 JPY
JPY
Extraordinary losses
54,628,000 JPY
JPY
Profit (loss) before income taxes
-1,301,630,000 JPY
-724,671,000 JPY
Income taxes - current
1,360,000 JPY
1,360,000 JPY
Profit (loss)
-1,302,990,000 JPY
-1,302,990,000 JPY
-1,302,990,000 JPY
-726,031,000 JPY
-726,031,000 JPY
-726,031,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.